Xenon Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	104.51	142.71	148.64	57.24	175.69	45.01
Short-Term Investments	357.75	484.19	489.44	534.85	376.09	131.99
Cash & Short-Term Investments	462.27	626.91	638.08	592.09	551.77	177
Cash Growth	-29.32%	-1.75%	7.77%	7.31%	211.74%	25.21%
Accounts Receivable	0.81	1.47	0.87	0.99	2.77	1.82
Receivables	0.81	1.47	0.87	0.99	2.77	1.82
Prepaid Expenses	17.06	6.89	6.01	7.23	4.48	2.96
Total Current Assets	480.14	635.26	644.96	600.3	559.02	181.78
Property, Plant & Equipment	15.85	18.22	18.85	16.91	12.52	6.88
Long-Term Investments	92.99	127.5	292.79	128.68	-	-
Long-Term Deferred Tax Assets	11.75	9.67	0.8	0.51	0.47	0.52
Other Long-Term Assets	7.11	7.5	7.4	7.75	-	-
Total Assets	607.84	798.14	964.8	754.15	572.01	189.19
Accounts Payable	4.55	5.07	8.6	8.49	3.82	3.04
Accrued Expenses	32.06	23.47	17.03	13.38	9.78	7.76
Current Portion of Leases	1.5	1.37	1.3	0.49	0.61	0.27
Current Income Taxes Payable	0.23	5.69	0.35	-	-	-
Current Unearned Revenue	-	-	-	-	-	3.64
Other Current Liabilities	-	-	-	0.34	0.12	0.07
Total Current Liabilities	38.34	35.59	27.27	22.7	14.32	14.78
Long-Term Leases	6.83	7.65	9.6	9.95	7.65	3.05
Other Long-Term Liabilities	3.16	-	-	-	-	-
Total Liabilities	48.33	43.24	36.88	32.65	21.97	17.83
Common Stock	1,475	1,457	1,436	1,065	790.9	405.48
Additional Paid-In Capital	223.78	199.15	156.76	142.11	117.5	45.36
Retained Earnings	-1,140	-899.47	-665.14	-482.75	-357.37	-278.49
Comprehensive Income & Other	0.48	-1.61	-0.08	-3	-0.99	-0.99
Shareholders' Equity	559.51	754.9	927.92	721.5	550.03	171.36
Total Liabilities & Equity	607.84	798.14	964.8	754.15	572.01	189.19
Total Debt	8.33	9.02	10.9	10.44	8.26	3.32
Net Cash (Debt)	546.93	745.39	919.97	710.33	543.52	173.68
Net Cash Growth	-31.08%	-18.98%	29.51%	30.69%	212.94%	39.05%
Net Cash Per Share	6.94	9.57	13.75	11.73	12.46	4.82
Filing Date Shares Outstanding	77.28	76.54	75.43	63.04	52.94	36.83
Total Common Shares Outstanding	77.12	76.42	75.37	62.59	52.65	36.03
Working Capital	441.8	599.67	617.69	577.6	544.7	167
Book Value Per Share	7.26	9.88	12.31	11.53	10.45	4.76
Tangible Book Value	559.51	754.9	927.92	721.5	550.03	171.36
Tangible Book Value Per Share	7.26	9.88	12.31	11.53	10.45	4.76
Machinery	-	14.38	11.89	11	10.8	12.32
Leasehold Improvements	-	9.36	9.02	4.2	7.02	6.39

Source: S&P Global Market Intelligence. Standard template. Financial Sources.